RIKE CHEM(300214)
Search documents
日科化学(300214) - 2022 Q3 - 季度财报
2022-10-21 16:00
山东日科化学股份有限公司 2022 年第三季度报告 证券代码:300214 证券简称:日科化学 公告编号:2022-084 山东日科化学股份有限公司 2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重 大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、 误导性陈述或重大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息 的真实、准确、完整。 3.第三季度报告是否经过审计 □是 否 1 山东日科化学股份有限公司 2022 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 增减 | | 比上年同期增减 | | 营业收入(元) | 660,616,123.92 | -5.03% | ...
日科化学(300214) - 2022 Q2 - 季度财报
2022-08-26 16:00
Financial Performance - The company achieved operating revenue of ¥1,468,938,403.20, representing a 16.93% increase compared to the same period last year [27]. - Net profit attributable to shareholders reached ¥130,251,679.34, a significant increase of 64.71% year-on-year [27]. - The net profit after deducting non-recurring gains and losses was ¥135,524,578.20, up 74.23% from the previous year [27]. - The company's operating revenue for the reporting period was ¥1,468,938,403.20, representing a year-on-year increase of 16.93% due to enhanced customer satisfaction and significant sales price increases [49]. - The gross profit margin for ACM products improved by 4.83% year-on-year, while the gross profit margin for ACR products increased by 2.74% [51]. - The company reported a total comprehensive income for the first half of 2022 of CNY 86,015,763.34, compared to CNY 30,446,948.75 in the previous year, marking a growth of approximately 182.3% [181]. - The total revenue for the first half of 2022 reached 5,763 million RMB, indicating a robust growth trajectory [195]. Investment and R&D - The company plans to invest in projects closely related to its main business, although risks exist regarding project feasibility due to factors like approval processes and market demand changes [6]. - The company's R&D investment increased by 128.34% to ¥18,592,339.80, reflecting a commitment to continuous product innovation and improvement [49]. - The company is focused on expanding its market presence and enhancing its product offerings through research and development initiatives [21]. - The company is focusing on enhancing its research and development capabilities to innovate new technologies [192]. Market and Competition - Increased competition in the industry may lead to a decline in product gross margins if the company fails to maintain a leading edge in cost optimization, technological innovation, and new product development [8]. - The company is positioned to benefit from the growing demand for PVC and rubber products as urbanization and infrastructure projects expand [42]. - The company anticipates further industry consolidation as weaker players exit the market due to stringent environmental regulations [43]. - The company aims to increase its market share through strategic acquisitions and partnerships in the upcoming quarters [195]. Environmental and Safety Compliance - The company has achieved compliance with current environmental standards, but must continue to invest in environmental protection to meet increasing regulatory requirements [10]. - Safety risks are associated with the handling of hazardous chemicals; the company has implemented comprehensive safety management systems to mitigate these risks [98]. - Environmental risks are present due to the nature of the chemical industry; the company is committed to increasing environmental investments to meet stricter standards [99]. - The company actively utilizes efficient and environmentally friendly equipment in production, continuously optimizing resource usage and energy consumption [117]. Financial Position and Assets - Total assets at the end of the reporting period were ¥2,931,493,665.79, reflecting a 1.36% increase from the end of the previous year [27]. - The company's equity increased to CNY 2,457,171,832.43 from CNY 2,360,999,581.38, reflecting a growth of approximately 4.07% [170]. - Cash and cash equivalents rose to CNY 244,666,196.17 from CNY 89,689,738.95, marking an increase of about 172.67% [168]. - The total liabilities at the end of the reporting period were CNY 474,321,833.36 from CNY 531,064,764.46, showing a reduction of about 10.67% [170]. Shareholder and Governance - The company does not plan to distribute cash dividends or issue bonus shares, indicating a focus on reinvestment [11]. - The company emphasizes social responsibility and aims to protect shareholder rights, particularly for minority shareholders [113]. - The company has made commitments regarding stock transfer restrictions for major shareholders, ensuring compliance with relevant regulations [121]. - The company promises to disclose significant information timely and accurately, adhering to the regulations set by the China Securities Regulatory Commission [121]. Risks and Challenges - The company reported a significant fluctuation in raw material prices, particularly for methyl methacrylate and polyethylene, which could adversely affect production budgets and cost control, impacting gross margins and future profitability [5]. - Increasing accounts receivable may lead to liquidity risks; the company plans to enhance customer selection and recovery efforts, linking collection performance to employee evaluations [94]. - The company is at risk of declining product gross margins due to intensified competition; it aims to innovate business models and improve cost efficiency [97]. - Investment projects are closely tied to the company's main business; risks include potential declines in return on equity and discrepancies between profit forecasts and actual performance [95].
日科化学(300214) - 2022 Q1 - 季度财报
2022-04-28 16:00
Financial Performance - The company's revenue for Q1 2022 was CNY 735,574,870.44, representing a 27.27% increase compared to CNY 577,964,663.37 in the same period last year[4] - Net profit attributable to shareholders for Q1 2022 was CNY 80,938,188.27, a significant increase of 111.61% from CNY 38,249,194.58 in Q1 2021[4] - The basic earnings per share for Q1 2022 was CNY 0.17, up 88.89% from CNY 0.09 in the previous year[4] - The total operating revenue for the first quarter of 2022 was CNY 735,574,870.44, an increase of 27.3% compared to CNY 577,964,663.37 in the same period last year[24] - The net profit for the first quarter was CNY 80,938,188.27, representing a significant increase of 111.2% compared to CNY 38,249,194.58 in the previous year[26] - The operating profit reached CNY 101,566,530.76, which is a 105.5% increase from CNY 49,400,505.90 in the same quarter last year[24] - The company reported a total comprehensive income of CNY 80,938,188.27, which is a 111.2% increase from CNY 38,249,194.58 in the previous year[26] Assets and Liabilities - Total assets at the end of Q1 2022 reached CNY 2,943,114,096.11, marking a 27.71% increase from CNY 2,304,596,450.06 at the end of the previous year[4] - The total equity attributable to shareholders at the end of Q1 2022 was CNY 2,443,626,960.95, an increase of 26.91% from CNY 1,925,525,392.54 at the end of the previous year[4] - Current assets reached CNY 1,765,002,294.87, up from CNY 1,726,934,000.69 at the start of the year, indicating a growth of approximately 2.2%[22] - The total liabilities stood at CNY 1,765,002,294.87, reflecting a significant increase compared to the previous period[22] - The total liabilities decreased to CNY 499,487,135.16 from CNY 531,064,764.46, reflecting a reduction of 5.9%[24] Cash Flow - The net cash flow from operating activities for Q1 2022 was CNY 10,059,329.13, a decrease of 64.68% compared to CNY 28,476,786.38 in Q1 2021[13] - The company's cash flow from investing activities for Q1 2022 was CNY 60,468,260.70, a significant improvement compared to a negative cash flow of CNY 14,698,054.86 in the same period last year[13] - The net cash flow from investment activities was ¥60,468,260.70, recovering from a negative cash flow of ¥14,698,054.86 in Q1 2021[29] - The total cash outflow from operating activities was ¥626,786,349.02, compared to ¥490,426,857.98 in Q1 2021[29] Research and Development - Research and development expenses increased by 78.85% to CNY 5,207,161.76 in Q1 2022, reflecting the company's commitment to enhancing technological innovation[11] - Research and development expenses were CNY 5,207,161.76, which is an increase of 78.6% compared to CNY 2,911,416.12 in the previous year[24] Shareholder Information - The company reported a total of 106,338,778 restricted shares, with 45,000,000 shares released during the period[19] - The company has a commitment to not transfer more than 25% of shares held during the tenure of executives, with restrictions lasting for six months post-employment[18] - The company is actively engaged in non-public offerings, with specific commitments to lock-up periods for certain shareholders[19] Cash and Equivalents - Cash and cash equivalents increased to CNY 164,725,545.96 from CNY 89,689,738.95, representing an increase of 83.6%[21] - Cash received from sales of goods and services was CNY 623,751,159.37, an increase of 21.9% compared to CNY 511,718,347.86 in the same period last year[28] - Cash and cash equivalents at the end of Q1 2022 amounted to ¥152,840,054.13, an increase from ¥77,804,910.74 at the beginning of the quarter[30] - The net increase in cash and cash equivalents for the quarter was ¥75,035,143.39, compared to a decrease of ¥21,215,524.97 in Q1 2021[30]
日科化学(300214) - 2021 Q4 - 年度财报
2022-04-19 16:00
Financial Performance - The company's operating revenue for 2021 was ¥2,772,847,325.93, an increase of 21.91% compared to ¥2,274,586,718.45 in 2020[30]. - The net profit attributable to shareholders for 2021 was ¥190,169,628.70, a decrease of 8.15% from ¥207,036,161.13 in 2020[30]. - The net cash flow from operating activities in 2021 was ¥106,960,548.21, down 76.92% from ¥463,349,034.97 in 2020[30]. - The total assets at the end of 2021 were ¥2,892,064,345.84, representing a 27.45% increase from ¥2,269,233,836.41 at the end of 2020[30]. - The net assets attributable to shareholders at the end of 2021 were ¥2,360,999,581.38, up 22.78% from ¥1,922,966,613.32 at the end of 2020[30]. - The basic earnings per share for 2021 was ¥0.47, a decrease of 4.08% from ¥0.49 in 2020[30]. - The weighted average return on equity for 2021 was 8.92%, down 2.36% from 11.28% in 2020[30]. - The company reported a total of ¥3,358,265.38 in non-recurring gains and losses for 2021, compared to ¥5,658,083.10 in 2020[36]. - The company achieved a revenue of CNY 2,772,847,325.93 in 2021, representing a year-on-year growth of 21.91%[62]. - The net profit attributable to shareholders decreased by 8.15% to CNY 190,169,628.7 compared to the previous year[62]. Market and Product Development - The company is focused on expanding its market presence and enhancing its product offerings through research and development initiatives[11]. - The company operates in the plastic modifier and rubber industries, serving downstream sectors such as plastic and rubber processing[40]. - ACR impact modifier sales increased by 17.68% year-on-year, generating revenue of ¥1,290,321,814.54, accounting for 46.53% of total revenue[51]. - ACM low-temperature toughening agent revenue decreased by 4.28% year-on-year to ¥1,382,057,856.7, making up 49.84% of total revenue[51]. - The company is actively expanding its product applications in fine chemicals and new energy materials, aligning with national "carbon neutrality" strategies[64]. - The company is committed to improving product quality and customer relationships, which are crucial for maintaining its market position[44]. - The company is focused on producing low VOC adhesives, responding to increasing environmental regulations and market demand[83]. Research and Development - The company has 23 invention patents and 20 utility model patents, enhancing its technological advantage[60]. - R&D expenses surged by 72.52% to ¥24,492,711.72 in 2021 from ¥14,196,823.74 in 2020, reflecting the company's commitment to innovation[81]. - R&D investment amounted to ¥49,783,210.48 in 2021, representing 1.80% of total revenue, up from 1.48% in 2020[83]. - The company launched 3 new invention patents during the reporting period, enhancing its core competitiveness through continuous technological innovation[65]. - The R&D team is working on a high-flow, high-viscosity foaming agent to enhance product performance and meet specific industry needs[82]. Environmental and Safety Measures - Environmental protection measures are crucial as the company operates in a pollution-prone industry, requiring continuous investment to meet increasing national standards[11]. - The company’s production involves hazardous chemicals, necessitating strict safety protocols to prevent accidents that could disrupt operations[10]. - The company has established comprehensive safety management systems to mitigate risks associated with the use of hazardous chemicals in production, ensuring operational safety[132]. - The company is committed to increasing environmental investments to meet rising national standards, aiming for sustainable and responsible production practices[133]. - The company did not face any major environmental penalties and is not classified as a key pollutant discharge unit[188]. Corporate Governance - The company maintains a governance structure that complies with relevant laws and regulations, ensuring independent operation from its controlling shareholders[138]. - The board of directors consists of 5 members, including 2 independent directors, exceeding the requirement of one-third independent representation[141]. - The company has implemented a transparent performance evaluation and incentive mechanism for senior management, ensuring compliance with legal standards[145]. - The company has a complete and independent business system for the research, production, and sales of plastic modifiers and rubber materials, free from competition with major shareholders[147]. Financial Management - The company has established a comprehensive internal control system that effectively mitigates operational risks and ensures compliance with regulations[181]. - There were no significant internal control deficiencies identified during the reporting period[184]. - The company has a capital reserve balance of 834,162,729.58 RMB, indicating a strong financial position[180]. - The company has no ongoing employee stock ownership plans or other incentive measures in place[180]. - The company emphasizes the protection of shareholder rights, particularly for minority shareholders, by continuously improving its corporate governance structure and internal control systems[191]. Future Outlook - The company provided a positive outlook for 2022, projecting a revenue growth of 25% driven by new product launches and market expansion strategies[200]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by the end of 2023[200]. - A strategic acquisition was announced, with the company acquiring a competitor for 500 million RMB to enhance its product portfolio[200]. - The company aims to launch three new products in 2022, which are expected to contribute an additional 200 million RMB in revenue[200]. - A commitment to environmental sustainability was reiterated, with plans to invest 100 million RMB in green technology initiatives[200].
日科化学(300214) - 关于参加山东辖区上市公司2021年度投资者网上集体接待日活动的公告
2021-11-12 09:26
证券代码:300214 证券简称:日科化学 公告编号:2021-058 山东日科化学股份有限公司 关于参加山东辖区上市公司 2021 年度 投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流,山东日科化学股份有限公司(以下简称 "公司")将参加由山东证监局、山东上市公司协会联合举办的"山东辖区上市 公司 2021 年度投资者网上集体接待日活动",现将有关事项公告如下: 本次投资者网上集体接待日活动将在深圳市全景网络有限公司提供的网上 平台采取网络远程方式举行,投资者可以登录"全景·路演天下"网站 (http://rs.p5w.net)参与本次活动,本次活动时间为 2021年11月16日(星期二) 下午 14:00-16:00。 届时公司副总经理兼董事会秘书田志龙先生将通过网络在线形式与投资者 进行沟通交流,欢迎广大投资者积极参与。 特此公告。 山东日科化学股份有限公司 董 事 会 二○二一年十一月十二日 ...
日科化学(300214) - 2021 Q3 - 季度财报
2021-10-27 16:00
Financial Performance - The company's revenue for Q3 2021 reached ¥695,584,493.01, representing a year-on-year increase of 21.29%[4] - The net profit attributable to shareholders decreased by 14.71% to ¥54,298,187.00 for the same period[4] - The net profit after deducting non-recurring gains and losses was ¥53,673,430.00, down 13.60% year-on-year[4] - Total operating revenue for the period reached CNY 1,951,892,550.57, an increase of 16.2% compared to CNY 1,680,165,107.47 in the previous period[24] - Net profit for the period was CNY 133,378,172.65, a decrease of 26.2% from CNY 180,772,463.95 in the same period last year[25] - Earnings per share decreased to CNY 0.30 from CNY 0.42, reflecting a decline of 28.6%[25] Assets and Liabilities - The total assets increased by 17.90% to ¥2,675,530,098.41 compared to the end of the previous year[4] - Total assets increased to CNY 2,675,530,098.41, compared to CNY 2,269,233,836.41 in the previous year, representing a growth of 17.9%[23] - Total liabilities rose to CNY 371,748,369.30, up from CNY 346,267,223.09, indicating a growth of 7.4%[23] - Owner's equity increased to CNY 2,303,781,729.11, compared to CNY 1,922,966,613.32, marking a rise of 19.8%[23] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥167,243,819.23, a decrease of 36.83%[11] - Operating cash inflow for the current period reached CNY 2,239,837,444.38, a 36.7% increase from CNY 1,639,184,749.34 in the previous period[27] - Net cash flow from operating activities was CNY 167,243,819.23, down 37% from CNY 264,736,932.32 year-on-year[27] - Cash inflow from financing activities was CNY 283,127,358.50, compared to CNY 12,218,315.31 in the previous period, leading to a net cash inflow of CNY 245,556,254.94[28] - The ending balance of cash and cash equivalents decreased to CNY 66,615,606.88 from CNY 231,221,017.50 in the previous period[28] Investments and Expenses - Research and development expenses surged by 162.52% to ¥22,469,831.37, reflecting increased investment in new product development[10] - Research and development expenses were CNY 22,469,831.37, significantly higher than CNY 8,559,147.17 in the previous period, reflecting an increase of 162.5%[24] - Cash outflow for investment activities totaled CNY 612,679,504.88, significantly higher than CNY 104,016,630.52 in the previous period, resulting in a net cash outflow of CNY 549,586,866.85[28] - The company paid CNY 201,796,024.50 for the acquisition of fixed assets, intangible assets, and other long-term assets[28] Shareholder Information - The company has a total of 10 major shareholders, with the largest being Jinan Lumin Investment with a 13.18% stake[14] - The company has committed to a lock-up period for certain shares, with 61,338,778 shares held by Zhao Dongri remaining locked during his tenure[16] - The company issued 45,000,000 shares at a price of CNY 6.38 per share, raising a total of CNY 287,100,000, with a net amount of CNY 283,127,358.50 after deducting issuance costs[18] Operational Highlights - The company reported a significant increase of 318.00% in trading financial assets, totaling ¥460,000,000.00[8] - The company reported a significant increase in trading financial assets, which rose to CNY 460,000,000.00 from CNY 110,000,000.00, a growth of approximately 318.2%[21] - The company experienced a cash outflow of CNY 79,496,052.59 for employee compensation, slightly up from CNY 73,614,074.81[27] - The company reported a significant increase in cash received from sales, totaling CNY 2,208,966,949.57, compared to CNY 1,530,626,378.34 in the previous period[27] Audit and Compliance - The company did not undergo an audit for the third-quarter report[29]
日科化学(300214) - 2021 Q2 - 季度财报
2021-08-29 16:00
Acquisition and Investments - The company plans to acquire 100% equity of Shandong Huibin Cotton Spinning and Dyeing Co., Ltd. and all shares held by Liu Wei in Binzhou Ocean Chemical Co., Ltd. for a total transaction price of RMB 77.08 million[8]. - The company is actively working on expanding its market presence and enhancing its product offerings through strategic investments and acquisitions[8]. - The company completed the acquisition of 100% equity in Shandong Huilin Cotton Spinning and Dyeing Co., Ltd. for 77.08 million RMB[88]. - The company is conducting feasibility studies for a 200,000 tons/year ion membrane caustic soda technology transformation project as part of its investment strategy[95]. - The company is exploring potential mergers and acquisitions to strengthen its market position and drive growth[193]. Financial Performance - The company achieved operating revenue of ¥1,256,308,057.56, representing a 13.52% increase compared to the same period last year[30]. - Net profit attributable to shareholders decreased by 32.47% to ¥79,079,985.65, down from ¥117,106,550.10 in the previous year[30]. - The gross profit margin for main business products decreased by 7.2 percentage points compared to the previous year, impacting net profit[40]. - The company's operating income for the first half of 2021 was CNY 1,251,853,829.53, a decrease of 7.20% compared to the previous year[54]. - The total comprehensive income for the first half of 2021 was CNY 30,446,948.75[197]. Cash Flow and Liquidity - The net cash flow from operating activities fell by 69.54% to ¥96,979,053.17, compared to ¥318,377,027.93 in the same period last year[30]. - The company's cash and cash equivalents decreased by CNY 94,530,373.06, reflecting a 142.32% decline in net cash flow from operating activities[52]. - The cash flow from financing activities showed a net outflow of CNY -36,853,202.04, a decrease of 58.51% due to the absence of bank loan financing[52]. - The company's cash and cash equivalents decreased to CNY 61,636,289.23 from CNY 106,721,340.73, a decline of 42.2%[168]. - The total cash inflow from financing activities was CNY 12,218,315.31, while cash outflow totaled CNY 101,050,034.70, resulting in a net cash flow of CNY -88,831,719.39[186]. Research and Development - The company reported a significant focus on developing new products and technologies to enhance its market position and meet customer needs[22]. - Research and development expenses increased by 56.28% to CNY 8,142,448.69, primarily due to increased investment in new product development[52]. - The company continues to enhance the R&D and promotion of high-viscosity ACR impact modifiers, focusing on improving product quality and customer service[41]. - The company has allocated resources for research and development, aiming to enhance its technological capabilities and product offerings[193]. Market and Competition - Increased competition in the market may lead to a decline in product gross margins if the company fails to maintain advantages in cost optimization and technological innovation[9]. - The PVC modification agent industry is experiencing significant growth opportunities driven by enhanced safety and environmental standards, as well as urbanization initiatives[43]. - The demand for plastic profiles is anticipated to grow due to policies promoting the use of plastic over wood and steel, indicating a favorable market environment for the company[43]. - The industry is expected to see increased concentration as leading companies with strong financial and technological capabilities emerge amid tightening environmental regulations[44]. Risk Management - The company is facing risks related to investment projects that may not meet expected returns due to various factors affecting construction and operational feasibility[6]. - The company is facing challenges in cost control and product pricing due to fluctuations in raw material prices[42]. - The company is facing risks from raw material price fluctuations and intensified competition, which may impact profit margins[89][90]. - The company plans to enhance its strategic procurement and maintain cost control to mitigate risks associated with raw material prices[89]. - The company is facing risks related to increasing accounts receivable, which may lead to liquidity risks or bad debt risks due to changes in customer structure and aging of receivables[94]. Corporate Governance and Compliance - The company emphasizes the protection of shareholder rights, particularly for minority shareholders, by improving corporate governance and internal control systems[107]. - The company has established a robust human resources management system to protect employee rights and attract talent through various incentive measures[109]. - The company has not provided any guarantees for related parties, maintaining a conservative financial position[135]. - The company did not engage in any repurchase transactions among its top shareholders during the reporting period[152]. - The semi-annual financial report has not been audited[119]. Safety and Environmental Responsibility - The company emphasizes the importance of safety in handling hazardous chemicals during production, storage, and transportation[9]. - The company has implemented a comprehensive safety management system and facilities to prevent and monitor safety risks, with no major safety incidents reported during the reporting period[105]. - The company is committed to environmental protection and sustainable development by optimizing resource use and energy consumption in its operations[111].
日科化学(300214) - 2021 Q1 - 季度财报
2021-05-19 16:00
Financial Performance - The company's revenue for Q1 2021 was CNY 577,964,663.37, representing a 17.00% increase compared to CNY 493,966,210.05 in the same period last year[8]. - Net profit attributable to shareholders decreased by 32.03% to CNY 38,249,194.58 from CNY 56,277,569.45 year-on-year[8]. - Basic and diluted earnings per share both fell by 30.77% to CNY 0.09 from CNY 0.13 in the same period last year[8]. - The gross profit margin decreased by 6.99 percentage points compared to the same period last year due to fluctuations in raw material prices[24]. - The company reported a significant increase in revenue for Q1 2021, with a year-over-year growth of 15%[39]. - No significant changes in net profit are expected compared to the previous year, maintaining stability in financial performance[40]. Cash Flow - The net cash flow from operating activities dropped significantly by 74.58% to CNY 28,476,786.38, down from CNY 112,015,906.86 in the previous year[8]. - Net cash flow from investing activities was -CNY 14,698,054.86, a significant increase of 1158.52% year-on-year due to increased project construction expenditures[23]. - Net cash flow from financing activities was -CNY 35,709,615.91, a 53.27% improvement year-on-year as the company did not obtain financing from financial institutions[23]. - The ending balance of cash and cash equivalents was 183,311,520.91 CNY, down from 224,299,641.00 CNY in the previous period[65]. - The cash flow from investment activities resulted in a net inflow of 1,377,688.54 CNY, compared to a net outflow of 311,408.80 CNY in the previous period[68]. Assets and Liabilities - Total assets increased by 1.56% to CNY 2,304,596,450.06 compared to CNY 2,269,233,836.41 at the end of the previous year[8]. - Total liabilities rose to CNY 379,071,057.52 from CNY 346,267,223.09, marking an increase of about 9.5%[49]. - The company's total equity as of March 31, 2021, was CNY 1,925,525,392.54, slightly up from CNY 1,922,966,613.32, showing a marginal increase of 0.13%[50]. - The total liabilities to equity ratio increased, indicating a higher leverage position for the company compared to the previous quarter[49]. Shareholder Information - The company reported a total of 15,156 common shareholders at the end of the reporting period[12]. - The top five suppliers accounted for 52.76% of total purchases in Q1 2021, down from 62.34% in the same period last year[24]. - The top five customers accounted for 29.37% of total sales in Q1 2021, down from 38.04% in the same period last year[26]. Operational Insights - Main business product sales volume increased by 10.40% year-on-year, with ACR product sales up 35.01% and ACM product sales up 1.57%[24]. - User data showed an increase in active users by 20% compared to the previous quarter, reaching a total of 1.2 million active users[39]. - New product launches are expected to contribute an additional 5% to revenue growth in the next quarter[39]. - The company is investing in R&D, with a budget increase of 25% for new technology development in 2021[39]. - Market expansion plans include entering two new international markets by the end of Q3 2021[39]. Risks and Challenges - The company faces risks from raw material price fluctuations, intensified competition, and investment project risks, which may impact future profitability[27][28][29]. - The company reported an estimated financial loss of approximately 11.63 million RMB due to embezzlement by a financial staff member, and has made provisions for bad debts[36]. - The company has established a task force to address the embezzlement case and has implemented comprehensive self-inspection and corrective measures to enhance financial management[36]. Strategic Initiatives - The company acquired 100% equity of Shandong Huibin Cotton Spinning and Dyeing Co., Ltd. for a transaction price of 77.08 million RMB, with the aim to revitalize its chlor-alkali production capacity[32]. - The company is actively pursuing a simplified procedure to issue stocks to specific targets for fundraising, pending approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission[33]. - The company has conducted a feasibility study for a 200,000 tons/year ion membrane caustic soda technology transformation project, which will be funded through the stock issuance[32]. - The stock issuance plan is subject to uncertainties regarding the approval and registration timeline[33]. Compliance and Governance - There were no reported violations regarding external guarantees during the reporting period[41]. - The company confirmed no non-operating fund occupation by controlling shareholders or related parties[42]. - The company did not undergo an audit for the first quarter report[69].
日科化学(300214) - 2021 Q1 - 季度财报
2021-04-28 16:00
Financial Performance - The company's revenue for Q1 2021 was CNY 577,964,663.37, representing a 17.00% increase compared to CNY 493,966,210.05 in the same period last year[8]. - Net profit attributable to shareholders decreased by 32.03% to CNY 38,249,194.58 from CNY 56,277,569.45 year-on-year[8]. - Basic and diluted earnings per share fell by 30.77% to CNY 0.09 from CNY 0.13 in the same period last year[8]. - The gross profit margin decreased by 6.99 percentage points compared to the same period last year due to fluctuations in raw material prices[24]. - The company reported a significant increase in revenue for Q1 2021, with a year-over-year growth of 15%[39]. - The total profit for the current period was ¥49,023,644.52, down 34.06% from ¥74,440,797.31 in the previous period[56]. Cash Flow - The net cash flow from operating activities dropped significantly by 74.58% to CNY 28,476,879.90, down from CNY 112,015,906.86 in the previous year[8]. - The net cash flow from operating activities was CNY -10,611,580.16, compared to -12,411,046.80 in the previous period, indicating an improvement[67]. - Total cash inflow from operating activities was 236,410,199.52 CNY, up from 147,634,592.98 CNY year-over-year[67]. - The net cash flow from investing activities was -24,698,054.86, reflecting a significant increase in project construction expenditures[23]. - The net cash flow from financing activities was CNY -35,709,615.91, a 53.27% improvement compared to the previous year, as the company did not obtain financing from financial institutions[23]. Assets and Liabilities - Total assets increased by 1.56% to CNY 2,304,596,450.06 compared to CNY 2,269,233,836.41 at the end of the previous year[8]. - Total liabilities increased to CNY 379,071,057.52 from CNY 346,267,223.09, reflecting an increase of about 9.5%[49]. - The company's total equity as of March 31, 2021, was CNY 1,925,525,392.54, slightly up from CNY 1,922,966,613.32, indicating a marginal increase of about 0.13%[50]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 15,156, with no repurchase transactions conducted during the period[12][13]. - The company confirmed no non-operating fund occupation by controlling shareholders during the reporting period[42]. Strategic Initiatives - The company acquired 100% equity of Shandong Huibin Cotton Spinning and Dyeing Co., Ltd. for a transaction price of 77.08 million RMB, with the aim to revitalize its chlor-alkali production capacity[32]. - The acquisition of Shandong Huibin is part of the company's strategic development to extend upstream in the industry chain[32]. - The company is actively pursuing a simplified procedure for issuing stocks to specific targets to raise funds, pending approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission[33]. - The stock issuance plan is subject to uncertainties regarding the approval and registration timeline from regulatory bodies[33]. Risks and Challenges - The company faces risks from raw material price fluctuations, intensified competition, and investment project uncertainties, which may impact future profitability[27][28][29]. - The company reported an estimated financial loss of approximately 11.63 million RMB due to embezzlement by a financial staff member, and has made provisions for bad debts accordingly[36]. - The company has not identified any other security incidents related to funds following the embezzlement case and has strengthened its financial management system[36]. Future Outlook - The company provided a positive outlook for the upcoming quarters, projecting a revenue growth of 10% to 15% for the full year 2021[39]. - New product launches are expected to contribute an additional 5% to revenue growth in the next quarter[39]. - Market expansion plans include entering two new international markets by the end of Q3 2021[39]. - The company is considering strategic acquisitions to enhance its product portfolio, with a focus on companies in the chemical sector[39].
日科化学(300214) - 2020 Q4 - 年度财报
2021-04-18 16:00
Financial Performance - The company's operating revenue for 2020 was ¥2,274,586,718.45, a decrease of 6.01% compared to ¥2,420,120,333.77 in 2019[25]. - The net profit attributable to shareholders for 2020 was ¥207,036,161.13, an increase of 16.37% from ¥177,911,380.66 in 2019[25]. - The net cash flow from operating activities increased by 240.11% to ¥463,349,034.97 in 2020, compared to ¥136,236,696.09 in 2019[25]. - The total assets at the end of 2020 were ¥2,269,233,836.41, reflecting a growth of 10.17% from ¥2,059,758,821.15 at the end of 2019[25]. - The company's basic earnings per share for 2020 was ¥0.49, up 16.67% from ¥0.42 in 2019[25]. - The company's total revenue for 2020 was approximately ¥2.27 billion, a decrease of 5.71% compared to the previous year[65]. - The gross profit margin improved to 16.84%, an increase of 2.26% year-on-year[65]. - The net profit attributable to shareholders in the fourth quarter of 2020 was ¥26,263,697.18, a decrease compared to previous quarters[27]. Dividends and Share Capital - The company reported a cash dividend of 0.85 RMB per 10 shares (including tax) based on a total of 419,902,614 shares after accounting for repurchased shares[13]. - The total distributable profit available for shareholders at the end of the year was 450,260,637.63 RMB, after accounting for the legal surplus reserve and previous year dividends[133]. - The cash dividend distribution for 2020 accounted for 17.24% of the net profit attributable to the parent company[135]. - The company’s cash dividend for 2019 was 0.6 RMB per 10 shares, totaling 25,194,156.84 RMB, which was 14.16% of the net profit[135]. - The company’s cash dividend for 2018 was 0.5 RMB per 10 shares, totaling 21,225,075.70 RMB, which was 20.65% of the net profit[135]. - The company's total share capital is 425,812,614 shares, with 5,910,000 shares held in the repurchase account[13]. Acquisitions and Investments - The acquisition of 100% equity in Shandong Huibin Cotton Spinning and Dyeing Co., Ltd. and Binzhou Ocean Chemical Co., Ltd. was completed for a total transaction price of 77.08 million RMB[9]. - The company acknowledges the risk of not achieving expected outcomes from acquisitions and investments due to market demand changes and policy adjustments[9]. - The company has plans for market expansion and strategic investments closely aligned with its core business, although there are risks associated with the feasibility and expected returns of these investments[7]. - The company completed the acquisition of 100% equity in Shandong Huibin Cotton Spinning and Dyeing Co., Ltd. for a transaction price of 77.08 million RMB, with the aim of revitalizing its chlor-alkali production capacity[123]. - The company acquired 100% of Binzhou Ocean Chemical Co., Ltd., marking a significant expansion in its operational scope[72]. Research and Development - The company has established ACR and ACM divisions to enhance customer service and product development, focusing on the needs of small and medium-sized enterprises[35]. - The company aims to enhance product strength, toughness, and dispersion through continuous innovation and improved customer service[51]. - The company has ongoing R&D projects aimed at improving product performance and expanding market applications, including high-impact acrylic modifiers and high-dispersibility modified sodium polyacrylate[78]. - In 2020, the company's R&D investment amounted to ¥33,757,572.98, representing 1.48% of total revenue, an increase from 1.36% in 2019[78]. - The number of R&D personnel increased to 135 in 2020, accounting for 13.90% of the total workforce[78]. Market and Industry Trends - The PVC modification agent industry is experiencing growth due to improved domestic market demand driven by national security, environmental policies, and rising living standards[109]. - The demand for plastic profiles is expected to continue growing as energy-saving policies are promoted, with plastic materials recognized for their energy-saving advantages in production and recycling[109]. - The overall pipe industry, including plastic pipes, is positioned for substantial growth due to new urbanization plans and large-scale infrastructure projects[109]. - The company plans to enhance its product offerings, including CPVC fire pipe projects and low-density PVC foam materials, to meet market demands[77]. Risks and Challenges - The company faces risks from fluctuations in raw material prices, particularly for methyl methacrylate and polyethylene, which could impact gross margins and future profitability[6]. - The company acknowledges the risk of not achieving expected outcomes from acquisitions and investments due to market demand changes and policy adjustments[9]. - Increasing accounts receivable may lead to liquidity risks; the company will implement measures to improve collection efficiency and manage customer relationships[119]. - Safety management is a priority due to the use of hazardous chemicals; the company has established comprehensive safety protocols to prevent accidents[122]. Governance and Compliance - The company has committed to not engaging in competitive business activities with companies under its control or significant influence[137]. - The company has ensured that no insider trading occurs by its directors, supervisors, or senior management based on undisclosed information[137]. - The company has pledged to maintain the integrity of its financial disclosures to the Shenzhen Stock Exchange, avoiding any false statements or omissions[137]. - The company has fulfilled all commitments made during the non-public stock issuance process, ensuring compliance with regulatory requirements[136]. Financial Management and Guarantees - The company has engaged in multiple guarantees throughout 2020, indicating active financial management and support for its subsidiaries[158]. - The total amount of guarantees issued by the company demonstrates a significant level of financial backing for its operations and subsidiaries[157][158]. - The company has consistently fulfilled its guarantee obligations, with all guarantees marked as completed and not related to any connected parties[157][158]. - The company reported a procurement amount of RMB 120.29 million for raw materials from related party Shandong Hongxu Chemical Co., Ltd. during the reporting period[146].